Novel Administration of Clofazimine for the Treatment of Infection.

Clicks: 189
ID: 108011
2020
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #32 of 239 articles by views in Open forum infectious diseases

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 239 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Clofazimine has demonstrated in vitro activity against many nontuberculous mycobacteria. We present the case of a woman with cystic fibrosis who developed disseminated macrolide-resistant infection following lung transplantation treated in part with clofazimine. We describe the novel administration of clofazimine via gastrostomy tube.
Reference Key
valinetz2020novelopen Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Valinetz, Ethan;Stankiewicz Karita, Helen;Pottinger, Paul S;Jain, Rupali;
Journal Open forum infectious diseases
Year 2020
DOI
10.1093/ofid/ofaa183
URL
Keywords
mycobacterium avium clofazimine lung transplant gastrostomy tube

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.